Articles with "cutaneous cell" as a keyword



Hemophagocytic Lymphohistiocytosis in Cutaneous T-Cell Lymphoma

Sign Up to like & get
recommendations!
Published in 2018 at "JAMA Dermatology"

DOI: 10.1001/jamadermatol.2018.1264

Abstract: Importance Hemophagocytic lymphohistiocytosis (HLH) has been reported as a serious complication of cutaneous T-cell lymphoma (CTCL). Despite available diagnostic guidelines, it remains a diagnostic and therapeutic challenge in this patient population. Objectives To examine the… read more here.

Keywords: cutaneous cell; hemophagocytic lymphohistiocytosis; cell; hlh ... See more keywords

Cutaneous T-Cell-Rich Lymphoid Infiltrates After SARS-CoV-2 Vaccination.

Sign Up to like & get
recommendations!
Published in 2022 at "JAMA dermatology"

DOI: 10.1001/jamadermatol.2022.2383

Abstract: Cutaneous T-Cell–Rich Lymphoid Infiltrates After SARS-CoV-2 Vaccination The most common skin reactions to mRNA-based vaccination against SARS-CoV-2 have included local and delayed injection site reactions and urticaria and have been more frequently associated with the… read more here.

Keywords: rich lymphoid; vaccination; lymphoid infiltrates; cell rich ... See more keywords

Incidence Trends of Primary Cutaneous T-Cell Lymphoma in the US From 2000 to 2018

Sign Up to like & get
recommendations!
Published in 2022 at "JAMA Oncology"

DOI: 10.1001/jamaoncol.2022.3236

Abstract: Using SEER database data, this cohort study analyzed cutaneous T-cell lymphoma incidence by tumor subtype, sex, age, race and ethnicity, socioeconomic status, and geography. read more here.

Keywords: cell lymphoma; incidence trends; cutaneous cell;

Cutaneous B‐cell lymphomas: 2019 update on diagnosis, risk stratification, and management

Sign Up to like & get
recommendations!
Published in 2018 at "American Journal of Hematology"

DOI: 10.1002/ajh.25224

Abstract: Approximately one‐fourth of cutaneous lymphomas are B‐cell derived and are generally classified into three distinct subgroups: primary cutaneous follicle center lymphoma (PCFCL), primary cutaneous marginal zone lymphoma (PCMZL), and primary cutaneous diffuse large B‐cell lymphoma,… read more here.

Keywords: cutaneous cell; lymphomas; lymphomas 2019; cell lymphomas ... See more keywords

Cutaneous T‐cell lymphomas: 2023 update on diagnosis, risk‐stratification, and management

Sign Up to like & get
recommendations!
Published in 2022 at "American Journal of Hematology"

DOI: 10.1002/ajh.26760

Abstract: Cutaneous T‐cell lymphomas are a heterogenous group of T‐cell neoplasms involving the skin, the majority of which may be classified as Mycosis Fungoides (MF) or Sézary Syndrome (SS). read more here.

Keywords: cell; 2023 update; lymphomas 2023; update diagnosis ... See more keywords
Photo from wikipedia

Critical concepts and management recommendations for cutaneous T‐cell lymphoma: A consensus‐based position paper from the Italian Group of Cutaneous Lymphoma

Sign Up to like & get
recommendations!
Published in 2020 at "Hematological Oncology"

DOI: 10.1002/hon.2832

Abstract: In this paper, we present a review of critical concepts, and produce recommendations on management issues in cutaneous T‐cell lymphomas (CTCLs) of adults. A panel of nine experts was selected for their expertise in research… read more here.

Keywords: cutaneous cell; paper; group; management ... See more keywords

The “m6A writer” METTL3 and the “m6A reader” IGF2BP2 regulate cutaneous T‐cell lymphomas progression via CDKN2A

Sign Up to like & get
recommendations!
Published in 2022 at "Hematological Oncology"

DOI: 10.1002/hon.3005

Abstract: It has been established that Cutaneous T‐Cell lymphomas (CTCL) are caused by the monoclonal proliferation of T lymphocytes in the skin. This heterogeneous group of diseases represents a significant source of distress to patients since… read more here.

Keywords: progression; ctcl; cell lymphomas; m6a ... See more keywords

Prevalence, tropism, and activity of cutavirus in circulating blood lymphocytes, stool, and skin biopsy specimens of patients with cutaneous T‐cell lymphoma and parapsoriasis en plaques

Sign Up to like & get
recommendations!
Published in 2024 at "Journal of Medical Virology"

DOI: 10.1002/jmv.29575

Abstract: A significant association has been established between a newly emerging human parvovirus, cutavirus (CuV), and cutaneous T‐cell lymphoma/mycosis fungoides (CTCL/MF) and its precursor parapsoriasis en plaques (PP). CTCL is a heterogeneous group of skin malignancies… read more here.

Keywords: cell lymphoma; cutaneous cell; cell; cuv ... See more keywords

Molecular profiling of TOX-deficient neoplastic cells in cutaneous T cell lymphoma

Sign Up to like & get
recommendations!
Published in 2019 at "Archives of Dermatological Research"

DOI: 10.1007/s00403-019-02000-0

Abstract: Cutaneous T cell lymphoma (CTCL) is a rare but potentially devastating primary cutaneous lymphoma. CTCL is characterized by localization of neoplastic T lymphocytes to the skin, with mycosis fungoides (MF) and its leukemic form, Sézary… read more here.

Keywords: cutaneous cell; ctcl; gene; cell ... See more keywords

Antibody-Based Therapies for Cutaneous T-Cell Lymphoma

Sign Up to like & get
recommendations!
Published in 2018 at "American Journal of Clinical Dermatology"

DOI: 10.1007/s40257-018-0402-5

Abstract: Cutaneous T-cell lymphomas (CTCLs) are a group of non-Hodgkin’s lymphomas that present in the skin. In early-stage disease, the course is generally chronic and indolent; however, in advanced stages of disease, therapies rarely provide long-lasting… read more here.

Keywords: cutaneous cell; antibody based; based therapies; antibody ... See more keywords

Novel cell adhesion/migration pathways are predictive markers of HDAC inhibitor resistance in cutaneous T cell lymphoma

Sign Up to like & get
recommendations!
Published in 2019 at "EBioMedicine"

DOI: 10.1016/j.ebiom.2019.07.053

Abstract: Background Treatment for Cutaneous T Cell Lymphoma (CTCL) is generally not curative. Therefore, selecting therapy that is effective and tolerable is critical to clinical decision-making. Histone deacetylase inhibitors (HDACi), epigenetic modifier drugs, are commonly used… read more here.

Keywords: cutaneous cell; acetylation; treatment; ctcl ... See more keywords